Aequus Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AQSZF research report →
About the company
Aequus Pharmaceuticals Inc. is a specialized pharmaceutical firm based in Vancouver, Canada, dedicated to the development and commercialization of medicinal products across the country. The company concentrates its efforts on several key medical disciplines, including neurological conditions, ophthalmology, and transplantation medicine.
- CEO
- Douglas Glen Janzen
- IPO
- 2015
- Employees
- 12
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $344.85K
- P/E
- -1.51
- P/S
- 0.95
- P/B
- -0.10
- EV/EBITDA
- -32.38
- Div Yield
- 0.00%
- Gross Margin
- 53.98%
- Op Margin
- -38.34%
- Net Margin
- -62.96%
- ROE
- 6.18%
- ROIC
- 30.88%
- Revenue
- $584.24K · 129.21%
- Net Income
- $-2,177,662 · 26.55%
- EPS
- $-0.02 · 26.79%
- Op Income
- $-2,127,199
- FCF YoY
- 27.81%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.19
- Avg Volume
- 252.69K
Get TickerSpark's AI analysis on AQSZF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our AQSZF coverage
Recent articles, reports, and earnings notes.
No research on AQSZF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AQSZF report →Similar companies
Peers in the same neighborhood.